Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Nuclear Medicine and Molecular Imaging
Published in: Nuclear Medicine and Molecular Imaging 1/2017

01-03-2017 | Review

Radiation Safety in Nuclear Medicine Procedures

Authors: Sang-Geon Cho, Jahae Kim, Ho-Chun Song

Published in: Nuclear Medicine and Molecular Imaging | Issue 1/2017

Login to get access

Abstract

Since the nuclear disaster at the Fukushima Daiichi Nuclear Power Plant in 2011, radiation safety has become an important issue in nuclear medicine. Many structured guidelines or recommendations of various academic societies or international campaigns demonstrate important issues of radiation safety in nuclear medicine procedures. There are ongoing efforts to fulfill the basic principles of radiation protection in daily nuclear medicine practice. This article reviews important principles of radiation protection in nuclear medicine procedures. Useful references, important issues, future perspectives of the optimization of nuclear medicine procedures, and diagnostic reference level are also discussed.
Literature
1.
2.
Song HC. Diagnostic reference levels in nuclear medicine imaging. Asia Ocean J Nucl Med Biol. 2015;3 Suppl 1:S55.
3.
Song HC. Current global and Korean issues in safety of nuclear medicine procedures. Supplement for the 3rd International Symposium on the System of Radiological Protection (ICRP). 2015;S22.
4.
Song HC. Diagnostic reference level in nuclear medicine. Supplement for the Annual Spring Meeting of the Korean Association for Radiation Protection. 2015:S47-61.
5.
ICRP. ICRP Publication 60: 1990 Recommendations of the International Commission on Radiological Protection. Ann ICRP. 1991;21(1–3).
6.
ICRP. ICRP publication 105: radiological protection in medicine. Ann ICRP. 2007;37(6).
7.
ICRP. ICRP publication 73: radiological protection and safety in medicine. Ann ICRP. 1996;26(2).
8.
9.
Mallick U, Harmer C, Yap B, Wadsley J, Clarke S, Moss L, et al. Ablation with low-dose radioiodine and thyrotropin Alfa in thyroid cancer. N Engl J Med. 2012;366:1674–85.CrossRefPubMed
10.
Schlumberger M, Catargi B, Borget I, Deandreis D, Zerdoud S, Bridji B, et al. Strategies of radioiodine ablation in patients with low-risk thyroid cancer. N Engl J Med. 2012;366:1663–73.CrossRefPubMed
11.
12.
13.
ICRP. ICRP publication 80: radiation dose to patients from radiopharmaceuticals (addendum to ICRP publication 53). Ann ICRP. 1998;28(3).
14.
ICRP. ICRP publication 106: radiation dose to patients from radiopharmaceuticals (addendum 3 to ICRP publication 53). Ann ICRP. 2007;38(1–2).
15.
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. Cancer J Clin. 2010;60:277–300.CrossRef
16.
Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 2012;380:499–505.CrossRefPubMedPubMedCentral
17.
Pierce DA, Preston DL. Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat Res. 2000;154:178–86.CrossRefPubMed
18.
Schauer DA, Linton OW. NCRP report no. 160, ionizing radiation exposure of the population of the united states, medical exposure-are we doing less with more, and is there a role for health physicists? Health Phys. 2009;97:1–5.CrossRefPubMed
19.
ICRP. ICRP publication 103. Ann ICRP. 2007;37(2–4).
20.
National Electrical Manufacturers Association. Computed Tomography Dose Check. NEMA Standards Publication XR 25–2010.
21.
ICRP. ICRP publication 94: release of patients after therapy with unsealed radionuclides. Ann ICRP. 2004;34(2).
22.
Wellner U, Eschner W, Hillger HW, Schicha H. The exposure of relatives to patients of a nuclear medical ward after radioiodine therapy by inhalation of I-131 in their home. Nuklearmedizin. 1998;37:113–9.PubMed
23.
IAEA. Radiation Protection and Safety of Radiation Sources: International Basic Safety Standards. IAEA Safety Standards for protecting people and the environment. General Safety Requirements Part 3. 1996.
24.
ICRP. ICRP publication 84: pregnancy and medical radiation. Ann ICRP. 2000;30(1).
25.
ICRP. ICRP publication 88: doses to the embryo and fetus from intakes of radionuclides by the mother. Ann ICRP. 2001;31(1–3).
26.
Boice Jr JD, Miller RW. Childhood and adult cancer after intrauterine exposure to ionizing radiation. Teratology. 1999;59:227–33.CrossRefPubMed
27.
Wakeford R. Childhood leukaemia following medical diagnostic exposure to ionizing radiation in utero or after birth. Radiat Prot Dosim. 2008;132:166–74.CrossRef
28.
Brent RL. The effect of embryonic and fetal exposure to X-ray, microwaves, and ultrasound: counseling the pregnant and nonpregnant patient about these risks. Semin Oncol. 1989;16:347–68.PubMed
29.
Laurier D, Jacob S, Bernier MO, Leuraud K, Metz C, Samson E, et al. Epidemiological studies of leukaemia in children and young adults around nuclear facilities: a critical review. Radiat Prot Dosim. 2008;132:182–90.CrossRef
30.
Chaparian A, Aghabagheri M. Fetal radiation doses and subsequent risks from X-ray examinations: should we be concerned? Iran J Reprod Med. 2013;11:899–904.PubMedPubMedCentral
31.
Wakeford R, Little MP. Risk coefficients for childhood cancer after intrauterine irradiation: a review. Int J Radiat Biol. 2003;79:293–309.CrossRefPubMed
32.
Wakeford R, Darby SC, Murphy MF. Temporal trends in childhood leukaemia incidence following exposure to radioactive fallout from atmospheric nuclear weapons testing. Radiat Environ Biophys. 2010;49:213–27.CrossRefPubMed
33.
Delongchamp RR, Mabuchi K, Yoshimoto Y, Preston DL. Cancer mortality among atomic bomb survivors exposed in utero or as young children. Radiat Res. 1997;147:385–95.CrossRefPubMed
34.
ICRP. ICRP publication 53: radiation dose to patients from radiopharmaceuticals. Ann ICRP. 1987;18(1).
35.
36.
Vogiatzi S, Kipouros P, Chobis M. Establishment of dose reference levels for nuclear medicine in Greece. Radiat Prot Dosim. 2011;147:237–9.CrossRef
37.
Roch P, Aubert B. French diagnostic reference levels in diagnostic radiology, computed tomography and nuclear medicine: 2004–2008 review. Radiat Prot Dosim. 2013;154:52–75.CrossRef
38.
Etard C, Celier D, Roch P, Aubert B. National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011. Radiat Prot Dosim. 2012;152:334–8.CrossRef
39.
Korpela H, Bly R, Vassileva J, Ingilizova K, Stoyanova T, Kostadinova I, et al. Recently revised diagnostic reference levels in nuclear medicine in Bulgaria and in Finland. Radiat Prot Dosim. 2010;139:317–20.CrossRef
40.
Brix G, Nosske D, Glatting G, Minkov V, Reske SN. A survey of PET activity in Germany during 1999. Eur J Nucl Med Mol Imaging. 2002;29:1091–7.CrossRefPubMed
41.
42.
Shannoun F, Blettner M, Schmidberger H, Zeeb H. Radiation protection in diagnostic radiology. Dtsch Arztebl Int. 2008;105:41–6.PubMedPubMedCentral
43.
Metadata
Title
Radiation Safety in Nuclear Medicine Procedures
Authors
Sang-Geon Cho
Jahae Kim
Ho-Chun Song
Publication date
01-03-2017
Publisher
Springer Berlin Heidelberg
Published in
Nuclear Medicine and Molecular Imaging / Issue 1/2017
Print ISSN: 1869-3474
Electronic ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-016-0406-0

Other articles of this Issue 1/2017

Nuclear Medicine and Molecular Imaging 1/2017 Go to the issue

Case Report

Primary Pulmonary Lymphoepithelioma-like Carcinoma on FDG PET/CT

Editorial

Message from the Editor-in-Chief 2017

Interesting Image

Scintigraphic Evidence for Overdiagnosis of Small PE on CT Pulmonary Angiography

Original Article

The Role of F-18 FDG PET/CT in Intrahepatic Cholangiocarcinoma

Original Article

18F-FDG PET/CT for the Diagnosis of Malignant and Infectious Complications After Solid Organ Transplantation

Review

Radio-graphene in Theranostic Perspectives